Diseases can be treated using viruses used as vector to deliver genes .In gene therapy viruses act as gene vector, however, can themselves cause problems in that they may initiate inflammation and the genes may be expressed at too high a level or for too long period of exposure. The goal of nano technology in gene therapy is delivery of therapeutic genes without a virus, using nanoparticles as non-viral vector to deliver the genes. The particles can be made with multiple layers so the outer layer with covering of peptide that can target the particles to cells of interest at specific site. The emerging technology called Nanotechnology which is used in gene therapy in order to develop unique approaches in treating the retinopathies and the development of micro and nano dimensional artificial antigen presenting cells (aAPCs) for cancer immunotherapy. These aAPCs mimic the natural signals in immunity that killer T-cells receive when there is an invader (bacteria, virus, cancer cell, etc.) in the body.
Recommended: Gene Therapy Conference | Gene Therapy Event | Gene therapy Meeting | Stem cells Conference | Molecular Biology Conference | Cell Biology Conference
Related Conferences: 2nd World Congress on Stem Cells and Regenerative Medicine, March 14-15, 2019, London, UK | International Conference on Molecular Biology and Stem Cells, November 19-20, 2018, Paris, France | World Congress on Tissue Engineering and Regenerative Medicine, March 14-15, 2019, London, UK | 10th International Conference on Genomics and Molecular Biology May 21-23, 2018, Barcelona, Spain
Related Associations and Societies: Europe: European society of Gene and cell therapy |Foundation for the Accreditation of Cellular Therapy| Alliance for Cancer Gene Therapy | Finnish Society of Gene Therapy| French Society of Cell Therapy and Genetics | Austrian Network for Gene Therapy| British Society of Gene Therapy (BSGT)| Turkish society of Gene and cell therapy| Swedish society of Gene and cell therapy |Spanish society of Gene and cell therapy
USA: American Society of Human Genetics (ASHG) | World Health Organization | American Society of Human Genetics| American Society for Cell Biology | Alliance for cellular signalling | American Society of Gene Therapy| American Association for Cancer Research| American Society of Gene and Cell Therapy
Asia: Australian Gene and Cell Therapy Society| Korean society of Gene and Cell Therapy | Japan society of Gene Therapy | Israeli society of Gene and Cell therapy | The International Centre for and Biotechnology | The Human Genome variation society | Australian Biotechnology Association| Australasian Proteomics Society
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
